Related Experiment Video
Updated: Aug 21, 2026

Viability Assay of Trichoderma stromaticum Conidia Inside Human Peripheral Blood Mononuclear-Derived Macrophages
Published on: October 20, 2023
Trichoderma spp. antagonism to the dermatophyte Trichophyton rubrum: implications in treatment of onychomycosis
1Department of Molecular Microbiology and Biotechnology, Faculty of Life Sciences, Tel Aviv Univresity, Tel Aviv 69978, Israel.
Abstract:
Onychomycosis--the dermatophytic invasion of the nail--is difficult to eradicate with drug treatment. The hyphae of the main invading pathogen, Trichophyton rubrum, are often interwoven with the nail plate, preventing effective anti-mycotic agents from reaching its growing tips. An alternative approach to treat onychomycosis may possibly be the application of a biological control agent against the pathogen. In analogy with the success of biocontrol of phytopathogenic fungi, we screened a series of commercially available Trichoderma strains for potential antagonism between Trichoderma and Trichophyton spp. A wide spectrum of antagonism capacity, ranging from effective overgrowth to no interaction was found, with Trichoderma virens NRRL 26672 being the most effective against the Trichophyton strains tested e.g. T. rubrum NCPF118. Furthermore, T. virens NRRL 26672 grown with T. rubrum NCPF118 hyphae as a carbon source, exhibited enhanced induced secretion of active extracellular chitinases and beta-glucosidases, affecting lysis and sporulation on T. rubrum NCPF118 hyphae. Growth of Trichod. virens NRRL 26672 in poor medium also resulted in secretion of antibiotics active in arresting the growth of T. rubrum NCPF118 inoculum. Our findings may open new directions for the treatment of onychomycosis, either in combination with known medications or as a new "natural" route.
Insights
Trichoderma virens NRRL 26672 shows promise for treating onychomycosis by inhibiting Trichophyton rubrum. This biological control agent secretes enzymes and antibiotics that disrupt fungal growth and sporulation.
Area of Science:
- Medical Mycology
- Biological Control
- Antimicrobial Agents
Background:
- Onychomycosis, a fungal nail infection, is challenging to treat due to pathogen resistance to antifungal drugs.
- The nail plate structure impedes the penetration of conventional antifungal medications to the site of infection.
Purpose of the Study:
- To explore the potential of biological control agents for treating onychomycosis.
- To screen Trichoderma strains for antagonistic activity against Trichophyton species, the primary cause of onychomycosis.
Main Methods:
- Screening of commercial Trichoderma strains for antagonism against Trichophyton spp.
- Culturing Trichoderma virens NRRL 26672 with Trichophyton rubrum hyphae as a carbon source.
- Analyzing the secretion of extracellular enzymes and antibiotics by Trichoderma virens.
Main Results:
- Trichoderma virens NRRL 26672 demonstrated significant antagonism against Trichophyton strains, including Trichophyton rubrum NCPF118.
- Enhanced secretion of chitinases and beta-glucosidases by T. virens, leading to lysis and reduced sporulation of T. rubrum.
- T. virens also produced antibiotics that inhibited the growth of T. rubrum inoculum.
Conclusions:
- Trichoderma virens NRRL 26672 is a potent biological control agent against onychomycosis-causing fungi.
- This study suggests a novel therapeutic strategy for onychomycosis using Trichoderma virens, potentially in combination with existing treatments or as a standalone natural remedy.
Related Concept Videos
Skin Diseases and Disorders
Gram-positive Staphylococcus spp. and Streptococcus spp. are responsible for many of the most common skin infections. However, many...
Trichomoniasis
Antifungal Agents
Antiprotozoal Agents
Acne Infection
Fungal Phylum Microsporidia

